Breaking News
Get 40% Off 0
🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For Free Copy Portfolio
Close

Biofrontera AG ADR (BFRA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Biofrontera ADR's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Biofrontera ADR historical data, for real-time data please try another search
2.670 0.000    0.00%
04/03 - Closed. Currency in USD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 2.600 - 3.100
Type:  Equity
Market:  United States
Biofrontera ADR 2.670 0.000 0.00%

Biofrontera ADR Company Profile

 
Read the Biofrontera AG ADR company profile to learn more about the business and the management team. View Biofrontera AG ADR facts about employee data, company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

95

Equity Type

ADR

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally. The company offers Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. It also provides RhodoLED XL lamp for the treatment of multiple interspersed lesions; and Belixos, a cosmetic product for irritated and sensitive skin. The company has a license and supply agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

Contact Information

Address Hemmelrather Weg 201
Leverkusen, 51377
Germany
Phone 49 214 87632 0
Fax 49 214 87632 90

Top Executives

Name Age Since Title
Humphrey Rang - - Head of the Scientific Advisory Board
Karlheinz Schmelig 58 2021 Member of the Supervisory Board
Heikki Lanckriet 47 2021 Member of the Supervisory Board
Helge Lubenow 55 2021 Member of the Supervisory Board
Jorgen Tielmann 54 2021 Vice-Chairman of the Supervisory Board
Wilhelm Konrad-Thomas Zours 63 2021 Chairman of the Supervisory Board
Karin Lergenmuller 65 2022 Member of Supervisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BFRA Price Commentary

Write your thoughts about Biofrontera AG ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jamal Ahmed
Jamal Ahmed Nov 24, 2020 15:38
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hello guys.Whats the news regarding BFRA?Is there any chance to reach $10 or $11..?
Jamal Ahmed
Jamal Ahmed Nov 24, 2020 15:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hello guys.Whats the news regarding BFRA?Is there any chance to reach $10 or $11..?
polonezu polo
polonezu polo Sep 14, 2020 19:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this will be boom!
Owen Huang
Owen Huang Aug 05, 2020 16:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email